HomeENSC • NASDAQ
add
Ensysce Biosciences Inc
Previous close
$2.14
Day range
$2.11 - $2.40
Year range
$1.62 - $14.67
Market cap
5.55M USD
Avg Volume
3.47M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 1.32M | 331.69% |
Operating expense | 3.29M | 139.99% |
Net income | -1.95M | 37.57% |
Net profit margin | -147.42 | 85.54% |
Earnings per share | -1.39 | 83.15% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.05M | -10.34% |
Total assets | 4.61M | -9.11% |
Total liabilities | 1.89M | 14.38% |
Total equity | 2.72M | — |
Shares outstanding | 2.37M | — |
Price to book | 1.16 | — |
Return on assets | -96.36% | — |
Return on capital | -147.72% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -1.95M | 37.57% |
Cash from operations | -1.71M | 49.91% |
Cash from investing | — | — |
Cash from financing | 1.26M | -77.89% |
Net change in cash | -449.59K | -119.71% |
Free cash flow | -1.14M | 41.32% |
About
Founded
2003
Headquarters
Website
Employees
8
